WESTPORT CT-Patients infected with both HIV and hepatitis C (HCV) often have significant amounts of HCV in their saliva.
This discovery is important because up to 40% of hepatitis C patients do not know the origin of their infection.
D. Rey, MD, from Hopitaux Universitaires in Strasbourg, France, said one third of patients had detectable levels of HCV RNA in their saliva with a mean level of 1.15 million genome equivalents per milliliter. Immune status and HIV risk group had no bearing on salivary positivity. However, a greater proportion of men than women had detectable levels of HCV RNA in their saliva.
There was no correlation between quantitative saliva and serum results. Qualitative results did show a significant direct association.
HCV is spread through contact of blood from an infected person.
Information from www.hivandhepatits.com, www.cdc.gov
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.